Le produit a bien été ajouté au panier.

discount label
Fluor-NLVPMVATV-OH
Vue en 3D

Biosynth logo

Fluor-NLVPMVATV-OH

Ref. 3D-PP47001

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mardi 3 décembre 2024

Informations sur le produit

Nom :
Fluor-NLVPMVATV-OH
Synonymes :
  • Fluor-Asn-Leu-Val-Pro-Met-Val-Ala-Thr-Val-OH
Description :

Peptide Fluor-NLVPMVATV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Fluor-NLVPMVATV-OH include the following: A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex XN Xu, MA Purbhoo, N Chen, J Mongkolsapaya - Immunity, 2001 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(01)00133-9.pdf Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes XH He, LH Xu, Y Liu - World Journal of Gastroenterology: WJG, 2005 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615439/ Combinatorial HLA-peptide bead libraries for high throughput identification of CD8+ T cell specificity X Pan, LC Huang, T Dong , Y Peng, V Cerundolo - Journal of , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175913003608 HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a VÎŽ1 variable segment T Ueno , H Tomiyama, M Fujiwara - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324148 Dipeptides promote folding and peptide binding of MHC class I molecules SK Saini , K Ostermeir - Proceedings of the , 2013 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1308672110 Dipeptides catalyze rapid peptide exchange on MHC class I molecules SK Saini , H Schuster - Proceedings of the , 2015 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1418690112 Altered peptide ligands revisited: Vaccine design through chemically modified HLA-A2-restricted T cell epitopes R Hoppes, R Oostvogels , JJ Luimstra - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/10/4803/97379 Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue MJ Maeurer , A Necker, RD Salter - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.1580 Synthesis and ex vivo profiling of chemically modified cytomegalovirus CMVpp65 epitopes MA Jones , JK Notta, M Cobbold - Journal of Peptide , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.930 Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins M Speir , A Authier-Hall, CR Brooks , KJ Farrand - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-14690-5 A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells M Sioud, G Skorstad, A Mobergslien - The FASEB , 2013 - Wiley Online Libraryhttps://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.12-224758 Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Delivery of large heterologous polypeptides across the cytoplasmic membrane of antigen-presenting cells by the Bordetella RTX hemolysin moiety lacking the J Holubova, J Kamanova, J Jelinek, J Tomala - Infection and , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/IAI.05711-11 Novel Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell J Bae, R Carrasco , AH Lee , R Prabhala , YT Tai - Blood, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006497119619166 A modified peptide stimulation method for efficient amplification of cytomegalovirus (CMV)-specific CTLs G Ruan, L Ma, Q Wen , W Luo, M Zhou - Cellular & Molecular , 2008 - nature.comhttps://www.nature.com/articles/cmi200824 Use of peptides and peptide libraries as T-cell stimulants in flow cytometric studies G Cherepnev, HD Volk , F Kern - Methods in cell biology, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0091679X04750189 Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules FT Ilca, A Neerincx, MR Wills - Proceedings of the , 2018 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1809465115 Analysis of antigen-specific T-cell responses with synthetic peptides-what kind of peptide for which purpose? F Kiecker, M Streitz, B Ay, G Cherepnev, HD Volk - Human immunology, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885904000539 Peptide-specific CD8+ T-cell evolution in vivo: Response to peptide vaccination with Melan-A/MART-1 E Jager, H Höhn, A Necker, R Förster - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.10165 In vivo activation of melanoma-specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells DE Speiser , D Lienard, MJ Pittet - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200203)32:3%3C731::AID-IMMU731%3E3.0.CO;2-H Oxidative stress can alter the antigenicity of immunodominant peptides D Weiskopf , A Schwanninger - Journal of leukocyte , 2010 - academic.oup.comhttps://academic.oup.com/jleukbio/article-abstract/87/1/165/6959842 Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer D Nobuoka, T Yoshikawa, M Takahashi - Cancer Immunology , 2013 - Springerhttps://link.springer.com/article/10.1007/s00262-012-1366-6 Human CD8+ T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase D Burbulla, PS Gunther , JK Peper, G Jahn - Viral , 2016 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.2015.0091 Random screening of proteins for HLA-A* 0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA C Pelte, G Cherepnev, Y Wang - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/11/6783/80929 Amino-terminal extended peptide single-chain trimers are potent synthetic agonists for memory human CD8+ T cells BM Carreno, M Becker-Hapak, M Chan - The Journal of , 2012 - journals.aai.orghttps://journals.aai.org/jimmunol/article/188/12/5839/85897 Rapid peptide exchange on MHC class I by small molecules elucidates dynamics of bound peptide A Hadeler, A Saikia , M Zacharias , S Springer - Current Research in , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2590255522000130

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP47001 Fluor-NLVPMVATV-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".